REVAGENIX INC
SAN MATEO, California
Total Received
$44.8M
Total Awards
2
State
California
Last Updated
Jan 26, 2026
Yearly Funding Trend
$44.8M24
Top 2 Awards to REVAGENIX INC
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through January 26, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
CONT_AWD_75N93020C00018_7529_-NONE-_-NONE- TO SELECT A NOVEL SMALL MOLECULE ANTIBIOTIC FOR CLINICAL DEVELOPMENT AND ADVANCE IT THROUGH IND FILING AND PHASE 1 CLINICAL STUDIES. | Department of Health and Human Services National Institutes of Health | — | SAN DIEGO, CA-50 | 2024 | $26,944,787 |
CONT_AWD_75N93022C00061_7529_-NONE-_-NONE- A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY. | Department of Health and Human Services National Institutes of Health | — | SAN MATEO, CA-15 | 2024 | $17,883,175 |
Top 2 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Funding Agencies
View All→Source: USAspending.gov · All Recipients · California